CD&R Creates Global Medical Communications Leader
Huntsworth Acquires Nucleus Global
LONDON and NEW YORK, Dec. 11, 2020 /PRNewswire/ Huntsworth, a Clayton, Dubilier & Rice portfolio company, has completed the previously announced acquisition of Nucleus Global, creating a global leader in Medical Communications. The terms of the transaction were not disclosed.
The combination with Nucleus further establishes Huntsworth as a leading Pharma Commercialization platform, offering a suite of medical affairs, market access, and marketing services to large and mid-size pharmaceutical and biotech companies across the life cycle of drugs.
CD&R funds made an initial investment in Huntsworth in May 2020, building on CD&R s long track record of investing in healthcare businesses.
CD&R Creates Global Medical Communications Leader | ANP Pers Support | De kortste weg naar publiciteit perssupport.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from perssupport.nl Daily Mail and Mail on Sunday newspapers.